Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
NCT06805994
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This protocol aims to evaluate how NMT affects pediatric nasal microbiome diversity following intranasal mupirocin treatment
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Staphylococcal Aureus Infection
- Microbial Colonization
- Pediatric Infection
- S. Aureus Colonization
- Microbial Transplant
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 0 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Johns Hopkins University
- Last updated on ClinicalTrials.gov
- August 10, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- Johns Hopkins University · Baltimore, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.